Amarin Corp Plc (AMRN)

[retinadoc]

Well stated. The combo pill should have been in development and ready for primetime. One more major fail for management. Zip is correct that it will bring brand awareness to Vascepa and rescue the US while litigation drags on. Amarin is once again delusional if they think that they can bring this to market with a GIA strategy. KM is a Europe specialist and needs to focus and stay in that lane. At the very least a joint venture with a BP for R&D, sales and marketing, needs to inked now or else the combo pill will be a cash black hole that will destroy what is left of shareholder value.

I think Sarissa knows this, we will see.